[go: up one dir, main page]

AR023138A1 - Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso - Google Patents

Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso

Info

Publication number
AR023138A1
AR023138A1 ARP000101294A ARP000101294A AR023138A1 AR 023138 A1 AR023138 A1 AR 023138A1 AR P000101294 A ARP000101294 A AR P000101294A AR P000101294 A ARP000101294 A AR P000101294A AR 023138 A1 AR023138 A1 AR 023138A1
Authority
AR
Argentina
Prior art keywords
composition
nicotine
tablets obtained
medicated chewing
medicated
Prior art date
Application number
ARP000101294A
Other languages
English (en)
Original Assignee
Licensing S A Atp Avant Garde Technologies & Product Marketing &
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI990571 external-priority patent/IT1311967B1/it
Application filed by Licensing S A Atp Avant Garde Technologies & Product Marketing & filed Critical Licensing S A Atp Avant Garde Technologies & Product Marketing &
Publication of AR023138A1 publication Critical patent/AR023138A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion para gomas de mascar medicadas que tienen el principio activo disperso en la goma y con un recubrimiento de una mezcla que comprende unelemento hidrosoluble y un elemento insoluble en agua. El principio activo puede ser uno o más delgrupo formado por nicotina, ibuprofeno, paracetamol,D-metorfano, dimenhidrinato, gengibre, ácido 1-ascorbico (vitamina C), acetilcisteína, efedrina, D-pseudoefedrina, valeriana, ranitidina, clorexidina, yodurode tibenzonio, preferentemente nicotina,mientras que el elemento soluble es un carbohidrato, preferentemente sorbitol, y el elemento insoluble es un aceite,preferentemente aceite hidrogenado de castor. También se describe un proceso para la fabricacion de una tableta de goma de mascar medicada que tiene lacomposicion de acuerdo a la presente. Las tabletas de acuerdo a la presente tienen gran estabilidad, importantes propiedades organolépticas, y propiedades parala liberacion gradual y controlada.
ARP000101294A 1999-03-22 2000-03-22 Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso AR023138A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI990571 IT1311967B1 (it) 1999-03-22 1999-03-22 Composizione per gomme da masticare medicate, procedimento per il loroottenimento e compresse cosi' ottenute.
US38753899A 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
AR023138A1 true AR023138A1 (es) 2002-09-04

Family

ID=26331646

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101294A AR023138A1 (es) 1999-03-22 2000-03-22 Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso

Country Status (10)

Country Link
EP (1) EP1162946B1 (es)
JP (1) JP2002539236A (es)
CN (1) CN1348359A (es)
AR (1) AR023138A1 (es)
AT (1) ATE451912T1 (es)
AU (1) AU6203799A (es)
BR (1) BR9917220A (es)
CA (1) CA2366845A1 (es)
DE (1) DE69941825D1 (es)
WO (1) WO2000056281A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20018196U1 (de) 2000-10-25 2001-01-11 Peter, Michael N., 22297 Hamburg Erzeugnis aus Zuckerware für Raucherentwöhnung
GB0107954D0 (en) * 2001-03-29 2001-05-23 Nestle Sa Chewing gum-containing tablet
ES2190730B1 (es) * 2001-06-11 2004-12-01 Farmalider, S.A. Composicion farmaceutica para tratar la congestion nasal via sistemica.
SE0102197D0 (sv) 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US7208186B2 (en) * 2001-09-18 2007-04-24 Spi Pharma, Inc. Chewing gum formulation and method of making the same
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US8293295B2 (en) * 2002-09-24 2012-10-23 Gumlink A/S Chewing gum comprising at least two different biodegradable polymers
DK3473251T3 (da) 2002-12-20 2024-01-22 Niconovum Ab Nikotin-cellulose-kombination
ATE405170T1 (de) * 2003-05-06 2008-09-15 Gumlink As Methode zur herstellung von kaugummigranulat und komprimierten kaugummiprodukten, sowie ein kaugummigranuliersystem
EP1817014B1 (en) 2004-11-30 2012-08-22 Fertin Pharma A/S Method of providing fast relief to a user of a nicotine chewing gum
CN102871987A (zh) * 2004-11-30 2013-01-16 费尔廷制药公司 尼古丁口香糖对使用者提供快速缓解的方法
US8323683B2 (en) * 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
RU2587570C2 (ru) 2010-04-14 2016-06-20 Алтрия Клаинт Сервисиз Инк. Отформованный бездымный табачный продукт
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
ZA201508730B (en) * 2014-12-01 2017-03-29 Michael T Rathogwa Decongestant gum

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB934596A (en) * 1961-05-08 1963-08-21 Warner Lambert Pharmaceutical Chewing gum
JPS60500519A (ja) * 1983-02-18 1985-04-18 ダブリユエム.ウリグリイ ジユニア カンパニ− チューインガム組成物
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4885175A (en) * 1987-12-23 1989-12-05 Wm. Wrigley Jr. Company Method of making chewing gum with wax-coated delayed release ingredients
IT1274034B (it) * 1994-07-26 1997-07-14 Applied Pharma Res Composizioni farmaceutiche a base di gomma da masticare e procedimento per la loro preparazione
US5693334A (en) * 1995-10-05 1997-12-02 Church & Dwight Co., Inc. Chewing gum product with dental health benefits

Also Published As

Publication number Publication date
ATE451912T1 (de) 2010-01-15
JP2002539236A (ja) 2002-11-19
EP1162946A1 (en) 2001-12-19
DE69941825D1 (de) 2010-01-28
AU6203799A (en) 2000-10-09
BR9917220A (pt) 2001-12-26
EP1162946B1 (en) 2009-12-16
CN1348359A (zh) 2002-05-08
CA2366845A1 (en) 2000-09-28
WO2000056281A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
AR023138A1 (es) Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso
Panda et al. Development of innovative orally fast disintegrating film dosage forms: a review
Bruschi et al. Oral bioadhesive drug delivery systems
US9937123B2 (en) Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents
JP5177447B2 (ja) 速溶性及び可撓性を有するフィルム製剤
JP6049624B2 (ja) 苦味のある薬物のための経口用医薬フィルム製剤
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
MXPA02003312A (es) Composiciones que tienen estabilidad mejorada.
CO6150127A2 (es) Formulaciones de flibanserina y metodo para fabricarlas
US10426725B2 (en) Self-supporting films for pharmaceutical and food use
AR039744A1 (es) Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
CA2505833A1 (en) Edible film for relief of cough or symptoms associated with pharyngitis
NZ501950A (en) Medicinal compositions for application to mucosa
US20090263467A1 (en) Combination drug therapy using orally dissolving film or orally disintegrating tablet dosage forms to treat dry mouth ailments
DE60312333D1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
Vishali et al. Orodispersible tablets: A review
CN101466369B (zh) 在牙齿或正畸牙套上使用的带凹陷的粘附性贴剂
KR100814253B1 (ko) 상전이 유도 구취제거제
UY27341A1 (es) Formulación farmacéutica de sabor enmascarado y procedimiento para su preparación.
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
US20130216594A1 (en) Preparation of orodispersible films
Gosavi et al. Mouth dissolving films: A review
ES2388139T3 (es) Forma posológica farmacéutica oral que comprende un fármaco antiinflamatorio no esteroideo y que presenta una buena palatabilidad
ATE242626T1 (de) Wasserlösliche pharmazeutische darreichungsform, ausgenommen brause-formen, welche nicht- steroidale antientzündliche wirkstoffe enthält
Bhagat et al. Orodispersible film: A novel drug delivery system